Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

GLP-1 physiology in obesity and development of incretin-based drugs for chronic weight management
Jens J. Holst
Nature Metabolism (2024) Vol. 6, Iss. 10, pp. 1866-1885
Open Access | Times Cited: 21

Showing 21 citing articles:

Adipose tissue retains an epigenetic memory of obesity after weight loss
Laura C. Hinte, Daniel Castellano‐Castillo, Adhideb Ghosh, et al.
Nature (2024)
Open Access | Times Cited: 36
Flavonoids for gastrointestinal tract local and associated systemic effects: A review of clinical trials and future perspectives
Xiaopeng Li, Enjun Xie, Shumin Sun, et al.
Journal of Advanced Research (2025)
Open Access | Times Cited: 2
GLP-1 and the Neurobiology of Eating Control: Recent Advances
Lauren A. Jones, Daniel I. Brierley
Endocrinology (2025)
Open Access | Times Cited: 2
Real‐world evidence on the utilization, clinical and comparative effectiveness, and adverse effects of newer GLP‐1RA‐based weight‐loss therapies
Reimar W. Thomsen, Aurélie Mailhac, Julie B. Løhde, et al.
Diabetes Obesity and Metabolism (2025)
Open Access | Times Cited: 1
Protein-responsive gut hormone tachykinin directs food choice and impacts lifespan
Nadja Ahrentløv, Olga I. Kubrak, Mette Lassen, et al.
Nature Metabolism (2025)
Open Access | Times Cited: 1
A dietary intervention following incretin analog treatment restores adipose tissue functions in diet-induced obese mice
Jan Seuntjens, Jente De Gols, Bethan K. Davies, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Dysregulation of Metabolic Peptides Precedes Hyperinsulinemia and Inflammation Following Exposure to Rotenone in Rats
Vandana Zaman, Denise Matzelle, Naren L. Banik, et al.
Cells (2025) Vol. 14, Iss. 2, pp. 124-124
Open Access
Case report: Long-term efficacy and safety of semaglutide in the treatment of syndromic obesity in Prader Willi syndrome - case series and literature review
Andrijana Koceva, Katarina Mlekuš Kozamernik, Andrej Janež, et al.
Frontiers in Endocrinology (2025) Vol. 15
Open Access
The agony and the efficacy: central mechanisms of GLP-1 induced adverse events and their mitigation by GIP
Jonathan D. Douros, Jonathan N. Flak, Patrick J. Knerr
Frontiers in Endocrinology (2025) Vol. 16
Open Access
Regulation of GLP-1 and Glucagon Receptor Function by β-Arrestins in Metabolically Important Cell Types
Liu Liu, Muhammad Rashid, Jürgen Wess
Biochemistry (2025)
Closed Access
Risk of depression and dementia among individuals treated with sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor agonists
Osvaldo P. Almeida
Current Opinion in Psychiatry (2025)
Closed Access
GLP-1 receptor agonists induce loss of lean mass: so does caloric restriction
Gabriele Mocciaro, Angelo Capodici, Ramona De Amicis
BMJ Nutrition Prevention & Health (2025), pp. bmjnph-001206
Open Access
2FA-Platform Generates Dual Fatty Acid-Conjugated GLP-1 Receptor Agonist TE-8105 with Enhanced Diabetes, Obesity, and NASH Efficacy Compared to Semaglutide
Melvin D.S. Wong, Pei‐Hsuan Lin, Wei‐Chen Lin, et al.
Journal of Medicinal Chemistry (2025)
Open Access
Liposomes Containing Tetraether Lipids and Cell‐Penetrating Peptides as Platform Technology for Oral Delivery of Peptides: A Comparative Study on GLP‐1 Analogs
Lorenz Herbster, Giulia Pander, Manuel Ben Böhmann, et al.
Nano Select (2025)
Open Access
Adipose tissue-targeting nanomedicines for obesity pharmacotherapy
Lingling Wang, Qingyi Jia, Jinhan He, et al.
Trends in Endocrinology and Metabolism (2025)
Open Access
Metabolic outcomes and safety of GLP-1 receptor agonists in children and adolescents with obesity: A systematic review and meta-analysis
Luis Gustavo Sedenho-Prado, Louise Buonalumi Tácito Yugar, Ana Raquel Whitaker, et al.
International Journal of Obesity (2025)
Closed Access
Gut Microbe-DerivedN-Acyl Serinol Lipids Shape Host Postprandial Metabolic Homeostasis
Sumita Dutta, Kala K. Mahen, William J. Massey, et al.
(2025)
Closed Access
HbA1c reduction strategies: An overview of pharmacological interventions
Krishna Upadhye, Hariom Patidar, Narendra Bamnia, et al.
National Journal of Pharmacology and Therapeutics (2025) Vol. 3, Iss. 1, pp. 24-33
Closed Access
Semaglutide improved sperm morphology in obese men with type 2 diabetes mellitus and functional hypogonadism
Nadan Gregorič, Jaka Šikonja, Andrej Janež, et al.
Diabetes Obesity and Metabolism (2024) Vol. 27, Iss. 2, pp. 519-528
Closed Access | Times Cited: 2
Glucagon‐Like Peptide‐1 Links Ingestion, Homeostasis, and the Heart
Jean‐Philippe Krieger, Derek Daniels, Shin Lee, et al.
Comprehensive physiology (2024) Vol. 15, Iss. 1
Closed Access | Times Cited: 2
Intestinal stearoyl-coenzyme A desaturase-inhibition improves obesity-associated metabolic disorders
Yangliu Xia, Yang Zhang, Zhipeng Zhang, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 15, Iss. 2, pp. 892-908
Open Access | Times Cited: 1
Editorial: Biological Therapies and Eating Disorders
Hubertus Himmerich, Beate Herpertz‐Dahlmann, Sabrina Mörkl
European Eating Disorders Review (2024)
Closed Access | Times Cited: 1
Fundamental role of brain-organ interaction in behavior-driven holistic homeostasis
Xinan Liu, Xulin Li, Peilei Shen, et al.
Fundamental Research (2024)
Open Access
Oxyntomodulin physiology and its therapeutic development in obesity and associated complications
Martin Tze Wah Kueh, Ming Chuen Chong, Alexander D. Miras, et al.
The Journal of Physiology (2024)
Open Access
Page 1

Scroll to top